Mr. Jeffery M. Brinza J.D. biography
Jeffery M. Brinza J.D. is the Interim Gen. Counsel at Millendo Therapeutics.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Mr D?
Mr D is 58, he's been the Interim Gen. Counsel of Millendo Therapeutics since . There are 6 older and 7 younger executives at Millendo Therapeutics. The oldest executive at Millendo Therapeutics, Inc. is John Howe, 77, who is the Independent Director.
What's Mr D's mailing address?
Jeffery's mailing address filed with the SEC is C/O MILLENDO THERAPEUTICS, INC., 301 N. MAIN ST., SUITE 100, ANN ARBOR, MI, 48104.
What does Millendo Therapeutics do?
Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.
What does Millendo Therapeutics's logo look like?
Millendo Therapeutics executives and stock owners
Millendo Therapeutics executives and other stock owners filed with the SEC include:
-
Julia Owens,
President, Chief Executive Officer, Director -
Louis Arcudi,
Chief Financial Officer -
Ryan Zeidan,
Chief Development Officer -
Dr. Julia C. Owens Ph.D.,
Exec. Chair of Board -
Louis J. Arcudi III, M.B.A., MBA,
CEO, Pres & Director -
Carol Gallagher,
Independent Chairman of the Board -
Connie Chang,
Vice President - Corporate Affairs -
Carole Nuechterlein,
Independent Director -
John Howe,
Independent Director -
James Hindman,
Independent Director -
Mary Hedley,
Independent Director -
Habib Dable,
Independent Director -
Geoffrey Nichol,
Independent Director -
Thomas Hoover,
Chief Commercial Officer -
Christophe Arbet-Engels,
Chief Medical Officer -
Tamara Joseph,
General Counsel, Corporate Secretary -
Denise Dorigo Jones,
VP of HR -
Jeffery M. Brinza J.D.,
Interim Gen. Counsel -
Jennifer Lynn Minai-Azary,
CFO & Principal Accounting Officer -
Jeffery M. Brinza,
Sec., CAO and General Counsel -
Randall W Whitcomb,
Director -
Pharis Mohideen,
Chief Medical Officer -
Jennifer Lynn Minai Azary,
Chief Financial Officer